These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37175376)

  • 21. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice.
    Onishi T; Matsumoto Y; Hattori M; Obayashi Y; Nakamura K; Yano T; Horiguchi T; Iwashita H
    Neurosci Res; 2014 Mar; 80():76-85. PubMed ID: 24406748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies.
    Mellone M; Kestoras D; Andrews MR; Dassie E; Crowther RA; Stokin GB; Tinsley J; Horne G; Goedert M; Tolkovsky AM; Spillantini MG
    J Neurosci; 2013 Nov; 33(46):18175-89. PubMed ID: 24227726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebral transcriptome analysis reveals age-dependent progression of neuroinflammation in P301S mutant tau transgenic male mice.
    Kim J; Selvaraji S; Kang SW; Lee WT; Chen CL; Choi H; Koo EH; Jo DG; Leong Lim K; Lim YA; Arumugam TV
    Brain Behav Immun; 2019 Aug; 80():344-357. PubMed ID: 30980950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model.
    Ando K; Leroy K; Heraud C; Kabova A; Yilmaz Z; Authelet M; Suain V; De Decker R; Brion JP
    Biochem Soc Trans; 2010 Aug; 38(4):1001-5. PubMed ID: 20658993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dephosphorylation Targeting Chimaera (DEPTAC): Targeting Tau Proteins in Tauopathies.
    Soumbasis A; Eldeeb MA; Ragheb MA; Zorca CE
    Curr Protein Pept Sci; 2022; 23(3):129-132. PubMed ID: 35598241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resveratrol Rescues Tau-Induced Cognitive Deficits and Neuropathology in a Mouse Model of Tauopathy.
    Sun XY; Dong QX; Zhu J; Sun X; Zhang LF; Qiu M; Yu XL; Liu RT
    Curr Alzheimer Res; 2019; 16(8):710-722. PubMed ID: 31368873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Islet amyloid polypeptide cross-seeds tau and drives the neurofibrillary pathology in Alzheimer's disease.
    Zhang G; Meng L; Wang Z; Peng Q; Chen G; Xiong J; Zhang Z
    Mol Neurodegener; 2022 Jan; 17(1):12. PubMed ID: 35093145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial Fusion Suppresses Tau Pathology-Induced Neurodegeneration and Cognitive Decline.
    Wang L; Liu M; Gao J; Smith AM; Fujioka H; Liang J; Perry G; Wang X
    J Alzheimers Dis; 2021; 84(3):1057-1069. PubMed ID: 34602490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
    Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A unique tau conformation generated by an acetylation-mimic substitution modulates P301S-dependent tau pathology and hyperphosphorylation.
    Ajit D; Trzeciakiewicz H; Tseng JH; Wander CM; Chen Y; Ajit A; King DP; Cohen TJ
    J Biol Chem; 2019 Nov; 294(45):16698-16711. PubMed ID: 31543505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition.
    Baglietto-Vargas D; Kitazawa M; Le EJ; Estrada-Hernandez T; Rodriguez-Ortiz CJ; Medeiros R; Green KN; LaFerla FM
    Neurobiol Dis; 2014 Feb; 62():407-15. PubMed ID: 24176788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.
    Jiang T; Yu JT; Zhu XC; Zhang QQ; Cao L; Wang HF; Tan MS; Gao Q; Qin H; Zhang YD; Tan L
    Neuropharmacology; 2014 Oct; 85():121-30. PubMed ID: 24880087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PM2.5 triggers tau aggregation in a mouse model of tauopathy.
    Liu C; Meng L; Gao Y; Chen J; Zhu M; Xiong M; Xiao T; Gu X; Liu C; Li T; Zhang Z
    JCI Insight; 2024 Jul; 9(14):. PubMed ID: 39133647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology.
    Leroy K; Ando K; Héraud C; Yilmaz Z; Authelet M; Boeynaems JM; Buée L; De Decker R; Brion JP
    J Alzheimers Dis; 2010; 19(2):705-19. PubMed ID: 20110614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuronal double-stranded DNA accumulation induced by DNase II deficiency drives tau phosphorylation and neurodegeneration.
    Li LJ; Sun XY; Huang YR; Lu S; Xu YM; Yang J; Xie XX; Zhu J; Niu XY; Wang D; Liang SY; Du XY; Hou SJ; Yu XL; Liu RT
    Transl Neurodegener; 2024 Aug; 13(1):39. PubMed ID: 39095921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Organotypic brain slice cultures of adult transgenic P301S mice--a model for tauopathy studies.
    Mewes A; Franke H; Singer D
    PLoS One; 2012; 7(9):e45017. PubMed ID: 22984603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Onset of hippocampal network aberration and memory deficits in P301S tau mice are associated with an early gene signature.
    Przybyla M; van Eersel J; van Hummel A; van der Hoven J; Sabale M; Harasta A; Müller J; Gajwani M; Prikas E; Mueller T; Stevens CH; Power J; Housley GD; Karl T; Kassiou M; Ke YD; Ittner A; Ittner LM
    Brain; 2020 Jun; 143(6):1889-1904. PubMed ID: 32375177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice.
    Schön C; Hoffmann NA; Ochs SM; Burgold S; Filser S; Steinbach S; Seeliger MW; Arzberger T; Goedert M; Kretzschmar HA; Schmidt B; Herms J
    PLoS One; 2012; 7(12):e53547. PubMed ID: 23300938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.